{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:58:36Z","timestamp":1790809116395,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273255"],"award-info":[{"award-number":["82273255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81821002"],"award-info":[{"award-number":["81821002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822034"],"award-info":[{"award-number":["81822034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82325039"],"award-info":[{"award-number":["82325039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1106600"],"award-info":[{"award-number":["2022YFA1106600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fundamental Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.fmre.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:40:10Z","timestamp":1765669210000},"page":"3381-3394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology"],"prefix":"10.1016","volume":"6","author":[{"given":"Yuting","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengnan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-5536","authenticated-orcid":false,"given":"Shengtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0001","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41573-022-00415-5","article-title":"Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment","volume":"21","author":"Petroni","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0002","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7791","key":"10.1016\/j.fmre.2025.12.009_bib0003","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.fmre.2025.12.009_bib0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.fmre.2025.12.009_bib0005","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ccell.2024.09.011","article-title":"A pan-cancer single-cell RNA-seq atlas of intratumoral B cells","volume":"42","author":"Fitzsimons","year":"2024","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.fmre.2025.12.009_bib0006","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1016\/j.cell.2024.06.038","article-title":"Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0007","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: Immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-023-01714-0","article-title":"Regulatory cells and the effect of cancer immunotherapy","volume":"22","author":"Iglesias-Escudero","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0009","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ccell.2024.12.006","article-title":"Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding","volume":"43","author":"Gao","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12991","article-title":"Immunoregulation by antibody secreting cells in inflammation, infection, and cancer","volume":"303","author":"McGettigan","year":"2021","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0012","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","article-title":"Tumor-reactive antibodies evolve from non-binding and autoreactive precursors","volume":"185","author":"Mazor","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0013","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cell.2017.07.026","article-title":"Clonal evolution of autoreactive germinal centers","volume":"170","author":"Degn","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.fmre.2025.12.009_bib0014","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic t-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0015","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0016","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41467-021-21245-w","article-title":"Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes","volume":"12","author":"Weiner","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0017","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0018","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.28020","article-title":"Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma","volume":"62","author":"Liu","year":"2015","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.fmre.2025.12.009_bib0019","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"7550","key":"10.1016\/j.fmre.2025.12.009_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"issue":"7850","key":"10.1016\/j.fmre.2025.12.009_bib0021","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.fmre.2025.12.009_bib0022","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0023","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13059-020-02064-6","article-title":"Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer","volume":"21","author":"Chen","year":"2020","journal-title":"Genome Biol."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0024","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: A focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.fmre.2025.12.009_bib0025","doi-asserted-by":"crossref","first-page":"eabb0737","DOI":"10.1126\/sciadv.abb0737","article-title":"Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0027","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1084\/jem.20092210","article-title":"S1P1 receptor directs the release of immature B cells from bone marrow into blood","volume":"207","author":"Allende","year":"2010","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.fmre.2025.12.009_bib0028","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1084\/jem.20140457","article-title":"CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow","volume":"211","author":"Beck","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0029","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","article-title":"Same yet different: How lymph node heterogeneity affects immune responses","volume":"24","author":"Cruz de Casas","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0030","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.fmre.2025.12.009_bib0031","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0032","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5943","key":"10.1016\/j.fmre.2025.12.009_bib0033","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"issue":"5943","key":"10.1016\/j.fmre.2025.12.009_bib0034","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.1176676","article-title":"Bcl6 mediates the development of T follicular helper cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: Building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0036","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: Cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0037","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3801","article-title":"The early history of B cells","volume":"15","author":"Cooper","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6360","key":"10.1016\/j.fmre.2025.12.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao2602","article-title":"The microanatomic segregation of selection by apoptosis in the germinal center","volume":"358","author":"Mayer","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.fmre.2025.12.009_bib0039","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","article-title":"Class-switch recombination occurs infrequently in germinal centers","volume":"51","author":"Roco","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.immuni.2018.03.027","article-title":"T follicular helper cell-germinal center B cell interaction strength regulates entry into plasma cell or recycling germinal center cell fate","volume":"48","author":"Ise","year":"2018","journal-title":"Immunity"},{"issue":"7619","key":"10.1016\/j.fmre.2025.12.009_bib0041","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature19334","article-title":"Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system","volume":"537","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.fmre.2025.12.009_bib0042","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.fmre.2025.12.009_bib0043","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2023.12.010","article-title":"Lack of affinity signature for germinal center cells that have initiated plasma cell differentiation","volume":"57","author":"Sutton","year":"2024","journal-title":"Immunity"},{"issue":"6732","key":"10.1016\/j.fmre.2025.12.009_bib0044","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.adr6896","article-title":"Affinity maturation of antibody responses is mediated by differential plasma cell proliferation","volume":"387","author":"MacLean","year":"2025","journal-title":"Science"},{"issue":"6230","key":"10.1016\/j.fmre.2025.12.009_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0046","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrc.2016.154","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0047","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2018.04.005","article-title":"Update on tumor neoantigens and their utility: Why it is good to be different","volume":"39","author":"Lee","year":"2018","journal-title":"Trends Immunol."},{"issue":"7913","key":"10.1016\/j.fmre.2025.12.009_bib0048","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"\u0141uksza","year":"2022","journal-title":"Nature"},{"issue":"7385","key":"10.1016\/j.fmre.2025.12.009_bib0049","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.fmre.2025.12.009_bib0050","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-13-3368","article-title":"Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer","volume":"20","author":"Iglesia","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.fmre.2025.12.009_bib0051","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw144","article-title":"Genomic analysis of immune cell infiltrates across 11 tumor types","volume":"108","author":"Iglesia","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0052","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0053","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.fmre.2025.12.009_bib0054","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129641","article-title":"Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer","volume":"4","author":"Garaud","year":"2019","journal-title":"JCI Insight"},{"issue":"6576","key":"10.1016\/j.fmre.2025.12.009_bib0055","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.fmre.2025.12.009_bib0056","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0057","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0058","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0059","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2019.01.012","article-title":"Programming isotype-specific plasma cell function","volume":"40","author":"Higgins","year":"2019","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0061","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nri.2016.2","article-title":"Mutations, kataegis and translocations in B cells: Understanding AID promiscuous activity","volume":"16","author":"Casellas","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0062","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccell.2023.02.017","article-title":"B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity","volume":"41","author":"Laumont","year":"2023","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0063","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153454","article-title":"An asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment","volume":"132","author":"Yang","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0064","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.fmre.2025.12.009_bib0065","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","article-title":"The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma","volume":"12","author":"Hao","year":"2022","journal-title":"Cancer Discov."},{"issue":"56","key":"10.1016\/j.fmre.2025.12.009_bib0066","doi-asserted-by":"crossref","first-page":"eabe6291","DOI":"10.1126\/sciimmunol.abe6291","article-title":"Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics","volume":"6","author":"King","year":"2021","journal-title":"Sci. Immunol."},{"issue":"6695","key":"10.1016\/j.fmre.2025.12.009_bib0067","doi-asserted-by":"crossref","first-page":"eadj4857","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0068","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0069","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma","volume":"10","author":"Griss","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.fmre.2025.12.009_bib0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2013.01.036","article-title":"The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer","volume":"333","author":"Lohr","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0071","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.5772","article-title":"Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer","volume":"255","author":"Backman","year":"2021","journal-title":"J. Pathol."},{"issue":"16","key":"10.1016\/j.fmre.2025.12.009_bib0072","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1158\/0008-5472.CAN-20-3773","article-title":"Tumor-infiltrating B lymphocyte profiling identifies igg-biased, clonally expanded prognostic phenotypes in triple-negative breast cancer","volume":"81","author":"Harris","year":"2021","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.fmre.2025.12.009_bib0073","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1093\/bioinformatics\/btw526","article-title":"Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer","volume":"32","author":"Mose","year":"2016","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.fmre.2025.12.009_bib0074","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nbt.3979","article-title":"Antigen receptor repertoire profiling from RNA-seq data","volume":"35","author":"Bolotin","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s40425-019-0747-1","article-title":"Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes","volume":"7","author":"Isaeva","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0076","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/0008-5472.CAN-21-2376","article-title":"IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer","volume":"82","author":"Mandal","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0077","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","article-title":"High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: Specific cell subtypes influence survival and determine molecular subtype classification","volume":"13","author":"Olbrecht","year":"2021","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0078","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-018-0339-x","article-title":"Landscape of B cell immunity and related immune evasion in human cancers","volume":"51","author":"Hu","year":"2019","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0079","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"7875","key":"10.1016\/j.fmre.2025.12.009_bib0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2931-3","article-title":"Defining HPV-specific B cell responses in patients with head and neck cancer","volume":"597","author":"Wieland","year":"2021","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.fmre.2025.12.009_bib0081","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.30966","article-title":"Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence","volume":"123","author":"Lang Kuhs","year":"2017","journal-title":"Cancer"},{"issue":"2 Suppl 2","key":"10.1016\/j.fmre.2025.12.009_bib0082","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.fmre.2025.12.009_bib0083","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-animal-021419-083720","article-title":"The immunoglobulins: New insights, implications, and applications","volume":"8","author":"Sun","year":"2020","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"16","key":"10.1016\/j.fmre.2025.12.009_bib0084","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"issue":"6195","key":"10.1016\/j.fmre.2025.12.009_bib0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1254836","article-title":"Clathrin adaptors. AP2 controls clathrin polymerization with a membrane-activated switch","volume":"345","author":"Kelly","year":"2014","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.fmre.2025.12.009_bib0086","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.it.2017.07.005","article-title":"TRIM21 and the function of antibodies inside cells","volume":"38","author":"Rhodes","year":"2017","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0087","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13046-019-1327-4","article-title":"RhoC: A fascinating journey from a cytoskeletal organizer to a cancer stem cell therapeutic target","volume":"38","author":"Thomas","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.fmre.2025.12.009_bib0088","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-11-2210","article-title":"A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin \u03ba C as a compatible prognostic marker in human solid tumors","volume":"18","author":"Schmidt","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0089","doi-asserted-by":"crossref","first-page":"e1181","DOI":"10.1002\/ctm2.1181","article-title":"Single-cell transcriptome analysis reveals functional changes in tumour-infiltrating B lymphocytes after chemotherapy in oesophageal squamous cell carcinoma","volume":"13","author":"Nakamura","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"16","key":"10.1016\/j.fmre.2025.12.009_bib0090","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.3390\/ijms23169124","article-title":"High IGKC-expressing intratumoral plasma cells predict response to immune checkpoint blockade","volume":"23","author":"Onieva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0091","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0092","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ijc.30138","article-title":"Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer","volume":"139","author":"Berntsson","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0093","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrm.2015.16","article-title":"Mechanisms of ephrin-Eph signalling in development, physiology and disease","volume":"17","author":"Kania","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.fmre.2025.12.009_bib0094","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1398-9995.2008.01768.x","article-title":"AllergoOncology: The role of IgE-mediated allergy in cancer","volume":"63","author":"Jensen-Jarolim","year":"2008","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0095","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41590-018-0161-8","article-title":"Epithelial damage and tissue \u03b3\u03b4 T cells promote a unique tumor-protective IgE response","volume":"19","author":"Crawford","year":"2018","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0096","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2020.03.002","article-title":"Harnessing therapeutic IgE antibodies to re-educate macrophages against cancer","volume":"26","author":"Pellizzari","year":"2020","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0097","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0098","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0099","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/0008-5472.CAN-16-1829","article-title":"Anti-folate receptor-\u03b1 IgE but not IgG recruits macrophages to attack tumors via TNF\u03b1\/MCP-1 signaling","volume":"77","author":"Josephs","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.fmre.2025.12.009_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ebiom.2019.03.080","article-title":"IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states","volume":"43","author":"Pellizzari","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0101","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002140","article-title":"Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2","volume":"9","author":"Pellizzari","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0102","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1038\/s41467-023-39679-9","article-title":"Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: A phase I trial","volume":"14","author":"Spicer","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0103","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0104","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41577-025-01137-6","article-title":"B cells in non-lymphoid tissues","volume":"25","author":"Samiea","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.fmre.2025.12.009_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101703","article-title":"Activation of B cells in tertiary lymphoid structures in cancer: Anti-tumor or anti-self ?","volume":"65","author":"Fridman","year":"2023","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0106","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1172\/JCI65579","article-title":"IgG4 subclass antibodies impair antitumor immunity in melanoma","volume":"123","author":"Karagiannis","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: Advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5844","key":"10.1016\/j.fmre.2025.12.009_bib0108","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"7680","key":"10.1016\/j.fmre.2025.12.009_bib0109","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0110","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1053\/j.gastro.2019.01.250","article-title":"Plasma cell polarization to the immunoglobulin G phenotype in hepatocellular carcinomas involves epigenetic alterations and promotes hepatoma progression in mice","volume":"156","author":"Wei","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0111","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/modpathol.2016.28","article-title":"Plasma cells in primary melanoma. Prognostic significance and possible role of IgA","volume":"29","author":"Bosisio","year":"2016","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0112","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/2326-6066.CIR-15-0214","article-title":"Comprehensive immune profiling of lung adenocarcinomas reveals four immunosubtypes with plasma cell subtype a negative indicator","volume":"4","author":"Kurebayashi","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.fmre.2025.12.009_bib0113","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12939","article-title":"Regulatory B cells in cancer","volume":"299","author":"Michaud","year":"2021","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.fmre.2025.12.009_bib0115","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1078-0432.CCR-12-0962","article-title":"Molecular pathways: Tumor-derived microvesicles and their interactions with immune cells in vivo","volume":"19","author":"Pucci","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0116","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"issue":"6282","key":"10.1016\/j.fmre.2025.12.009_bib0117","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science"},{"issue":"7353","key":"10.1016\/j.fmre.2025.12.009_bib0118","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.fmre.2025.12.009_bib0119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","article-title":"FcRgamma activation regulates inflammation-associated squamous carcinogenesis","volume":"17","author":"Andreu","year":"2010","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccr.2014.04.026","article-title":"B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas","volume":"25","author":"Affara","year":"2014","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0121","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","article-title":"Tumor cells hijack macrophage-produced complement C1q to promote tumor growth","volume":"7","author":"Roumenina","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"12","key":"10.1016\/j.fmre.2025.12.009_bib0122","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fmre.2025.12.009_bib0123","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10346","article-title":"C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation","volume":"7","author":"Bulla","year":"2016","journal-title":"Nat. Commun."},{"issue":"6068","key":"10.1016\/j.fmre.2025.12.009_bib0124","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1126\/science.1215173","article-title":"Innate response activator B cells protect against microbial sepsis","volume":"335","author":"Rauch","year":"2012","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.2569","article-title":"Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR\u03b3t and Ahr that leads to IL-17 production by activated B cells","volume":"14","author":"Bermejo","year":"2013","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bj.2019.05.008","article-title":"Regulatory functions of B cells and regulatory plasma cells","volume":"42","author":"Fillatreau","year":"2019","journal-title":"Biomed. J."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2018.06.007","article-title":"LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells","volume":"49","author":"Lino","year":"2018","journal-title":"Immunity"},{"issue":"7710","key":"10.1016\/j.fmre.2025.12.009_bib0128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0129","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.fmre.2025.12.009_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0090-4295(76)90384-8","article-title":"Diagnostic significance of levels of immunoglobulin A in seminal fluid of patients with prostatic disease","volume":"8","author":"Shah","year":"1976","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.fmre.2025.12.009_bib0132","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41577-022-00719-y","article-title":"Tumour immunotherapy: Lessons from predator-prey theory","volume":"22","author":"Hamilton","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.fmre.2025.12.009_bib0133","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/icb.2009.120","article-title":"Induction of interleukin-10 expression through Fcalpha receptor in human monocytes and monocyte-derived dendritic cells: Role of p38 MAPKinase","volume":"88","author":"Pilette","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0134","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.humpath.2013.01.002","article-title":"Stromal plasma cells expressing immunoglobulin G4 subclass in non-small cell lung cancer","volume":"44","author":"Fujimoto","year":"2013","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0135","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00262-016-1853-2","article-title":"Immunoglobulin G4 (IgG4)-positive plasma cell infiltration is associated with the clinicopathologic traits and prognosis of pancreatic cancer after curative resection","volume":"65","author":"Liu","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0136","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1880687","article-title":"IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer","volume":"10","author":"Jordakieva","year":"2021","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0137","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: Immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7550","key":"10.1016\/j.fmre.2025.12.009_bib0138","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature14424","article-title":"Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity","volume":"521","author":"Carmi","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.fmre.2025.12.009_bib0139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fmre.2025.12.009_bib0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.fmre.2025.12.009_bib0141","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","article-title":"Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: A proposal for quantitative immune-related pathologic response criteria (irPRC)","volume":"29","author":"Cottrell","year":"2018","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0142","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","article-title":"Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer","volume":"40","author":"Patil","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0143","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41568-023-00637-8","article-title":"Fc\u03b3 receptors and immunomodulatory antibodies in cancer","volume":"24","author":"Galvez-Cancino","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0144","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1038\/s41467-023-39367-8","article-title":"SEC-seq: Association of molecular signatures with antibody secretion in thousands of single human plasma cells","volume":"14","author":"Cheng","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0145","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1186\/s12967-024-05768-6","article-title":"CD38 as theranostic target in oncology","volume":"22","author":"Bocuzzi","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0147","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006262","article-title":"Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)","volume":"11","author":"Siddiqui","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.fmre.2025.12.009_bib0148","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.immuni.2024.02.005","article-title":"Tuning of plasma cell lifespan by competition explains the longevity and heterogeneity of antibody persistence","volume":"57","author":"Simons","year":"2024","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.fmre.2025.12.009_bib0149","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: The challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.fmre.2025.12.009_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108733","article-title":"Plasma cell dynamics in the bone marrow niche","volume":"34","author":"Benet","year":"2021","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0151","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/annonc\/mdh280","article-title":"Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma","volume":"15","author":"Aklilu","year":"2004","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0152","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-lived plasma cells are contained within the CD19-CD38hiCD138+ subset in human bone marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.fmre.2025.12.009_bib0153","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.immuni.2023.04.015","article-title":"Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan","volume":"56","author":"Robinson","year":"2023","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.fmre.2025.12.009_bib0154","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129641","article-title":"Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer","volume":"5","author":"Garaud","year":"2019","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.fmre.2025.12.009_bib0155","doi-asserted-by":"crossref","first-page":"eabb0737","DOI":"10.1126\/sciadv.abb0737","article-title":"Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.fmre.2025.12.009_bib0156","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s40425-019-0747-1","article-title":"Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes","volume":"7","author":"Isaeva","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.fmre.2025.12.009_bib0157","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.fmre.2025.12.009_bib0158","article-title":"Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity","volume":"3","author":"Mirlekar","year":"2022","journal-title":"Cell Rep. Med."}],"container-title":["Fundamental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325825007319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325825007319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:58:35Z","timestamp":1790805515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667325825007319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":158,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2667325825007319"],"URL":"https:\/\/doi.org\/10.1016\/j.fmre.2025.12.009","relation":{},"ISSN":["2667-3258"],"issn-type":[{"value":"2667-3258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology","name":"articletitle","label":"Article Title"},{"value":"Fundamental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fmre.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}